Synthesis Fe3O4@MCM-41-Urokinase Nano-Composite as an Advanced Drug Delivery System

[1]  F. Shirini,et al.  Synthesis of Tetrahydrobenzo[b]pyran and Pyrano[2, 3-d]pyrimidinone Derivatives Using Fe₃O₄@Ph-PMO-NaHSO₄ as a New Magnetically Separable Nanocatalyst. , 2019, Journal of nanoscience and nanotechnology.

[2]  F. Shirini,et al.  Fe3O4@MCM-41-(SO3−)[ZrO2] Magnetic Mesoporous Nanocomposite: Dispersive Solid-Liquid Micro Extraction of Pb2+ Ions , 2019, Silicon.

[3]  Jianqing Gao,et al.  Recent strategies on targeted delivery of thrombolytics , 2019, Asian journal of pharmaceutical sciences.

[4]  Aldenor G. Santos,et al.  Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles , 2019, Scientific Reports.

[5]  A. Shtil,et al.  Urokinase-Conjugated Magnetite Nanoparticles as a Promising Drug Delivery System for Targeted Thrombolysis: Synthesis and Preclinical Evaluation. , 2018, ACS applied materials & interfaces.

[6]  H. K. Manjili,et al.  Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin , 2017, Drug Research.

[7]  Y. Ghasemi,et al.  Synthesis and Application of Amine Functionalized Iron Oxide Nanoparticles on Menaquinone-7 Fermentation: A Step towards Process Intensification , 2015, Nanomaterials.

[8]  Md. Ramjan Ali,et al.  Aspect of Thrombolytic Therapy: A Review , 2014, TheScientificWorldJournal.

[9]  M. A. Malik,et al.  A direct synthesis of water soluble monodisperse cobalt and manganese ferrite nanoparticles from iron based pivalate clusters by the hot injection thermolysis method , 2014 .

[10]  G. Raskob,et al.  Thrombosis: a major contributor to global disease burden. , 2014, Thrombosis research.

[11]  A. Rastegari,et al.  Characterization of Modified Magnetite Nanoparticles for Albumin Immobilization , 2014, Biotechnology research international.

[12]  R. Bongiovanni,et al.  Synthesis and organic functionalization approaches for magnetite (Fe 3 O 4 ) nanoparticles , 2012 .

[13]  H. Gu,et al.  Targeted thrombolysis by using of magnetic mesoporous silica nanoparticles. , 2012, Journal of biomedical nanotechnology.

[14]  M. Marden,et al.  Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections , 2011, American journal of hematology.

[15]  J. Ardisson,et al.  Study of mesoporous silica/magnetite systems in drug controlled release , 2009, Journal of materials science. Materials in medicine.

[16]  M. Penn,et al.  Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets. , 2008, Biomaterials.

[17]  Hongchen Gu,et al.  Development of high magnetization Fe3O4/polystyrene/silica nanospheres via combined miniemulsion/emulsion polymerization. , 2006, Journal of the American Chemical Society.

[18]  German Salazar-Alvarez,et al.  Novel flow injection synthesis of iron oxide nanoparticles with narrow size distribution , 2006 .

[19]  S. Kahn,et al.  Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. , 2002, Archives of internal medicine.

[20]  C. Metreweli,et al.  The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong. , 1988, International journal of cardiology.

[21]  E. Teller,et al.  ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .